Furthermore, insulin sensitizers combined with anti-androgen drugs could be a more effective method for treating metabolic syndrome and advanced PCa patients.178,179 In the future, a new generation of treatment options targeting androgen synthesis or directly targeting AR in combination with ADT will have the potential to better manage PCa patients’ metabolic and cardiovascular risk factors and complications. Here, INS is linked to metabolic syndrome.